Please use this identifier to cite or link to this item:
|Title:||Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage.||Austin Authors:||Osicka, Tanya M;Houlihan, Christine A ;Chan, J Gordon ;Jerums, George ;Comper, Wayne D||Affiliation:||Department of Medicine, Austin & Repatriation Medical Center, University of Melbourne, Heidelberg, Victoria, Australia||Issue Date:||1-Sep-2000||Publication information:||Diabetes; 49(9): 1579-84||Abstract:||Previous studies by our group have shown that albumin is metabolized in rodents during renal passage and excreted in the urine as a mixture of intact protein and albumin-derived fragments. The aim of this study was to examine whether albumin is metabolized during renal passage in nondiabetic volunteers and in type 1 diabetic patients with varying levels of albuminuria. Nine nondiabetic normoalbuminuric volunteers and 11 type 1 diabetic patients with albumin excretion rates varying from normoalbuminuria to macroalbuminuria were studied. Each subject received an intravenous injection of tritium-labeled albumin ([3H]-albumin). Urine was collected at 4 h and 24 h after injection and analyzed by size exclusion chromatography. The amount of intact and fragmented albumin was quantified, and each fraction was analyzed by radioimmunoassay (RIA) for albumin. [3H]-albumin in nondiabetic volunteers was metabolized during renal passage to small peptide fragments not detectable by conventional RIA (only 0.05-3.8% of the total urinary radioactivity was associated with intact albumin). The process responsible for albumin fragmentation was similar in diabetic patients with normoalbuminuria (intact albumin represented 0.01-4.0% of total urinary radioactivity). However, there was a reduction in the fragmentation ratio (fragmented:intact) in diabetic patients with micro- or macroalbuminuria (intact albumin represented 2.7-55.5%, P = 0.048). This change in the fragmentation ratio was directly related to the degree of albuminuria. These results have important implications for understanding the mechanisms underlying albuminuria in nondiabetic volunteers and type 1 diabetic patients. In nondiabetic volunteers, the renal processing of albumin involves a relatively rapid and comprehensive degradation of albumin to small fragments (range 1-15 kDa). The degradation process is inhibited in diabetic nephropathy in proportion to the level of albuminuria detected by RIA.||Gov't Doc #:||10969843||URI:||http://ahro.austin.org.au/austinjspui/handle/1/9245||URL:||https://pubmed.ncbi.nlm.nih.gov/10969843||Type:||Journal Article||Subjects:||Adult
Diabetes Mellitus, Type 1.physiopathology.urine
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 8, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.